Landscape Capital Management, L.L.C. Pliant Therapeutics, Inc. Transaction History

Landscape Capital Management, L.L.C.

  • $887 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024
BUY
$12.85 - $19.15 $207,476 - $309,195
16,146 New
16,146 $292,000
Q1 2023

May 10, 2023
SELL
$18.73 - $36.26 $82,730 - $160,160
-4,417 Reduced 17.58%
20,712 $550,000
Q4 2022

Feb 09, 2023
BUY
$17.0 - $25.43 $427,193 - $639,030
25,129 New
25,129 $485,000

Others Institutions Holding PLRX

# of Institutions
168
Shares Held
63.2M
Call Options Held
245K
Put Options Held
373K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $600M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Landscape Capital Management, L.L.C. Portfolio

Follow Landscape Capital Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email